Sanofi H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations

NCT00963157 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

789

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

DRUG: AS03
BIOLOGICAL: Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)